Analysis of recent trends in prostate cancer incidence and mortality

Leslie K Dennis, Martin I. Resnick

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

BACKGROUND. There is debate over whether the recent increases seen in prostate cancer are due to lead-time bias from screening, or identification of clinically insignificant lesions. METHODS. Population-based incidence rates for 1973-1996 were calculated, based on the Surveillance, Epidemiology, and End Results Program (SEER) tumor registries. Relative incidence rates for prostate cancer by stage, fatal incidence, and lymph nodes were calculated, adjusted for age. RESULTS. Localized and regional stage prostate cancer increased through 1992 and then dropped. The rate of distant-stage disease was relatively stable from 1973-1991, with a decrease in distant stage starting in 1992. The 2-year mortality rates were constant for 1973-1989. A decline in the 2-year mortality among cases (fatal incidence) also began in 1992. CONCLUSIONS. These data show large increases in early disease, followed by a drop and leveling off along with a decrease in advanced disease (distant stage, 2-year mortality, positive lymph nodes). This indicates that the increasing incidence rates for prostate cancer are largely due to lead-time bias from increased early detection and treatment of prostate cancer. However, since incidence rates have not declined to rates seen in the 1970s, the additional cases may also reflect length bias from insignificant lesions or a true increase in incidence over time. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)247-252
Number of pages6
JournalProstate
Volume42
Issue number4
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Mortality
Incidence
Lymph Nodes
SEER Program
Registries
Population
Neoplasms

Keywords

  • Bias
  • Incidence
  • Mass screening
  • Prostatic neoplasms
  • Registries
  • SEER Program

ASJC Scopus subject areas

  • Urology

Cite this

Analysis of recent trends in prostate cancer incidence and mortality. / Dennis, Leslie K; Resnick, Martin I.

In: Prostate, Vol. 42, No. 4, 2000, p. 247-252.

Research output: Contribution to journalArticle

Dennis, Leslie K ; Resnick, Martin I. / Analysis of recent trends in prostate cancer incidence and mortality. In: Prostate. 2000 ; Vol. 42, No. 4. pp. 247-252.
@article{19549c016cd74aa087ade6f21305aaad,
title = "Analysis of recent trends in prostate cancer incidence and mortality",
abstract = "BACKGROUND. There is debate over whether the recent increases seen in prostate cancer are due to lead-time bias from screening, or identification of clinically insignificant lesions. METHODS. Population-based incidence rates for 1973-1996 were calculated, based on the Surveillance, Epidemiology, and End Results Program (SEER) tumor registries. Relative incidence rates for prostate cancer by stage, fatal incidence, and lymph nodes were calculated, adjusted for age. RESULTS. Localized and regional stage prostate cancer increased through 1992 and then dropped. The rate of distant-stage disease was relatively stable from 1973-1991, with a decrease in distant stage starting in 1992. The 2-year mortality rates were constant for 1973-1989. A decline in the 2-year mortality among cases (fatal incidence) also began in 1992. CONCLUSIONS. These data show large increases in early disease, followed by a drop and leveling off along with a decrease in advanced disease (distant stage, 2-year mortality, positive lymph nodes). This indicates that the increasing incidence rates for prostate cancer are largely due to lead-time bias from increased early detection and treatment of prostate cancer. However, since incidence rates have not declined to rates seen in the 1970s, the additional cases may also reflect length bias from insignificant lesions or a true increase in incidence over time. (C) 2000 Wiley-Liss, Inc.",
keywords = "Bias, Incidence, Mass screening, Prostatic neoplasms, Registries, SEER Program",
author = "Dennis, {Leslie K} and Resnick, {Martin I.}",
year = "2000",
doi = "10.1002/(SICI)1097-0045(20000301)42:4<247::AID-PROS1>3.0.CO;2-5",
language = "English (US)",
volume = "42",
pages = "247--252",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Analysis of recent trends in prostate cancer incidence and mortality

AU - Dennis, Leslie K

AU - Resnick, Martin I.

PY - 2000

Y1 - 2000

N2 - BACKGROUND. There is debate over whether the recent increases seen in prostate cancer are due to lead-time bias from screening, or identification of clinically insignificant lesions. METHODS. Population-based incidence rates for 1973-1996 were calculated, based on the Surveillance, Epidemiology, and End Results Program (SEER) tumor registries. Relative incidence rates for prostate cancer by stage, fatal incidence, and lymph nodes were calculated, adjusted for age. RESULTS. Localized and regional stage prostate cancer increased through 1992 and then dropped. The rate of distant-stage disease was relatively stable from 1973-1991, with a decrease in distant stage starting in 1992. The 2-year mortality rates were constant for 1973-1989. A decline in the 2-year mortality among cases (fatal incidence) also began in 1992. CONCLUSIONS. These data show large increases in early disease, followed by a drop and leveling off along with a decrease in advanced disease (distant stage, 2-year mortality, positive lymph nodes). This indicates that the increasing incidence rates for prostate cancer are largely due to lead-time bias from increased early detection and treatment of prostate cancer. However, since incidence rates have not declined to rates seen in the 1970s, the additional cases may also reflect length bias from insignificant lesions or a true increase in incidence over time. (C) 2000 Wiley-Liss, Inc.

AB - BACKGROUND. There is debate over whether the recent increases seen in prostate cancer are due to lead-time bias from screening, or identification of clinically insignificant lesions. METHODS. Population-based incidence rates for 1973-1996 were calculated, based on the Surveillance, Epidemiology, and End Results Program (SEER) tumor registries. Relative incidence rates for prostate cancer by stage, fatal incidence, and lymph nodes were calculated, adjusted for age. RESULTS. Localized and regional stage prostate cancer increased through 1992 and then dropped. The rate of distant-stage disease was relatively stable from 1973-1991, with a decrease in distant stage starting in 1992. The 2-year mortality rates were constant for 1973-1989. A decline in the 2-year mortality among cases (fatal incidence) also began in 1992. CONCLUSIONS. These data show large increases in early disease, followed by a drop and leveling off along with a decrease in advanced disease (distant stage, 2-year mortality, positive lymph nodes). This indicates that the increasing incidence rates for prostate cancer are largely due to lead-time bias from increased early detection and treatment of prostate cancer. However, since incidence rates have not declined to rates seen in the 1970s, the additional cases may also reflect length bias from insignificant lesions or a true increase in incidence over time. (C) 2000 Wiley-Liss, Inc.

KW - Bias

KW - Incidence

KW - Mass screening

KW - Prostatic neoplasms

KW - Registries

KW - SEER Program

UR - http://www.scopus.com/inward/record.url?scp=0033965424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033965424&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0045(20000301)42:4<247::AID-PROS1>3.0.CO;2-5

DO - 10.1002/(SICI)1097-0045(20000301)42:4<247::AID-PROS1>3.0.CO;2-5

M3 - Article

C2 - 10679753

AN - SCOPUS:0033965424

VL - 42

SP - 247

EP - 252

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 4

ER -